Poster Session: COVID-19: Treatment
Anil K. Gupta, MD
Albion Finch Medical Centre
Toronto, Ontario, Canada
Maria Teresa Perez-Rodríguez, MD
2Hospital Álvaro Cunqueiro, Vigo, Pontevedra, Galicia sur Health Research Institute
Pontevedra, Galicia, Spain
Yaneicy Gonzalez-Rojas, MD
Optimus U Corp
Miami, Florida, United States
Moti Ramgopal, MD, FACP, FIDSA
Medical Director
Midway Immunology and Research Center
Fort Pierce, FL, United States
Almena Free, MD
Pinnacle Research Group, LLC
Anniston, Alabama, United States
Jennifer Han, MD
Sr. Clinical Development Director, Clinical Sciences (Infectious Diseases and Virology)
GlaxoSmithKline
Collegeville, Pennsylvania, United States
Jennifer Moore, MD
GlaxoSmithKline
Brentford, England, United Kingdom
Rudrani Banerjee, PhD
GSK
Bangalore, Karnataka, India
Phillip Yates, PhD
GSK
Stevenage, England, United Kingdom
Jill Walker, PhD
Group Leader, Clinical Virology
GlaxoSmithKline
Cambridge, Massachusetts, United States
Gretja Schnell, PhD
Vir Biotechnology, Inc.
San Francisco, California, United States
Mary Beth Connolly, PharmD
GSK
Research Triangle Park, North Carolina, United States
Andrea L. Cathcart, PhD
Vir Biotechnology, Inc.
San Francisco, California, United States
Varsha Imber, MSc
GSK
Brentford, England, United Kingdom
Rabia Anselm, n/a
GSK
Brentford, England, United Kingdom
Lindsay Winograd, MSc
GSK
Mississauga, Ontario, Canada
Nancy Haeusser, n/a
GSK
Collegeville, Pennsylvania, United States
Scott Segal, MD
GSK
Collegeville, Pennsylvania, United States
Andrew Skingsley, MD
GlaxoSmithKline
Brentford, England, United Kingdom
Melissa Aldinger, PharmD
Vir Biotechnology, Inc.
San Francisco, California, United States
Amanda Peppercorn, MD
GlaxoSmithKline
Cambridge, Massachusetts, United States
Jaynier Moya, MD
Pines Care Research Center LLC
Pembroke Pines, Florida, United States